Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A Carpenter

Showing results (51-60 of 178) with videos related to

Pageof 18
Sort By:
Blood|January 8, 2005
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemiaJean E Sanders, Ho Joon Im, Paul A Hoffmeister, et al.
Haematologica|February 16, 2015
Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trialMarco Mielcarek, Terrence Furlong, Barry E Storer, et al.
Transplantation and Cellular Therapy|October 2, 2022
American Society for Transplantation and Cellular Therapy Return to Work Guidance Committee Recommendations for Health Care Providers Who Take Care of Hematopoietic Cell Transplantation PatientsRachel B Salit, Katie Schoeppner, Chiara De Biase, et al.
JAMA Network Open|July 28, 2021
Seroprevalence of Measles and Mumps Antibodies Among Individuals With CancerSara R Marquis, Jennifer K Logue, Helen Y Chu, et al.
Blood|January 15, 2016
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantationMarco Mielcarek, Terry Furlong, Paul V O'Donnell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2018
Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host DiseaseAreej El-Jawahri, Joseph Pidala, Nandita Khera, et al.
Transplantation and Cellular Therapy|July 8, 2023
Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular TherapyAbraham S Kanate, Navneet Majhail, Zachariah DeFilipp, et al.
The Journal of Allergy and Clinical Immunology|July 21, 2010
Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndromeLauri M Burroughs, Troy R Torgerson, Rainer Storb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donorsTerry Furlong, Hans-Peter Kiem, Frederick R Appelbaum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2015
Bandage Soft Contact Lenses for Ocular Graft-versus-Host DiseaseYoshihiro Inamoto, Yi-Chen Sun, Mary E D Flowers, et al.
Pageof 18

Showing results (51-60 of 178) with videos related to

Sort By:
Pageof 18
Blood|January 8, 2005
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemiaJean E Sanders, Ho Joon Im, Paul A Hoffmeister, et al.
Haematologica|February 16, 2015
Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trialMarco Mielcarek, Terrence Furlong, Barry E Storer, et al.
Transplantation and Cellular Therapy|October 2, 2022
American Society for Transplantation and Cellular Therapy Return to Work Guidance Committee Recommendations for Health Care Providers Who Take Care of Hematopoietic Cell Transplantation PatientsRachel B Salit, Katie Schoeppner, Chiara De Biase, et al.
JAMA Network Open|July 28, 2021
Seroprevalence of Measles and Mumps Antibodies Among Individuals With CancerSara R Marquis, Jennifer K Logue, Helen Y Chu, et al.
Blood|January 15, 2016
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantationMarco Mielcarek, Terry Furlong, Paul V O'Donnell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2018
Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host DiseaseAreej El-Jawahri, Joseph Pidala, Nandita Khera, et al.
Transplantation and Cellular Therapy|July 8, 2023
Updated Indications for Immune Effector Cell Therapy: 2023 Guidelines from the American Society for Transplantation and Cellular TherapyAbraham S Kanate, Navneet Majhail, Zachariah DeFilipp, et al.
The Journal of Allergy and Clinical Immunology|July 21, 2010
Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndromeLauri M Burroughs, Troy R Torgerson, Rainer Storb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donorsTerry Furlong, Hans-Peter Kiem, Frederick R Appelbaum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2015
Bandage Soft Contact Lenses for Ocular Graft-versus-Host DiseaseYoshihiro Inamoto, Yi-Chen Sun, Mary E D Flowers, et al.
Pageof 18